Complementary medicine use in children and young adults with inflammatory bowel disease.
about
Measurement properties of questionnaires assessing complementary and alternative medicine use in pediatrics: a systematic reviewComplementary and alternative medicine treatments for children with autism spectrum disordersRandomized controlled trials in pediatric complementary and alternative medicine: where can they be found?Probiotics in inflammatory bowel diseases and associated conditionsThe use of complementary and alternative medicine in children with common neurologic diseasesUse of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.Pediatricians' attitudes, experience and referral patterns regarding Complementary/Alternative Medicine: a national survey.Factors and common conditions associated with adolescent dietary supplement use: an analysis of the National Health and Nutrition Examination Survey (NHANES).Predictors of medication adherence in pediatric inflammatory bowel disease patients at the Stollery Children's HospitalMind-body complementary alternative medicine use and quality of life in adolescents with inflammatory bowel diseaseComplementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis.Chiropractic approach to the management of children.Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.Predictors for adolescent visits to practitioners of complementary and alternative medicine in a total population (the Young-HUNT Studies).Response to strict and liberalized specific carbohydrate diet in pediatric Crohn's disease.A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.Functional abdominal pain and irritable bowel syndrome in children and adolescents.Herbal medicines for children.Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidencePolypharmacy and Crohn's disease.Don't ask, don't tell: parental nondisclosure of complementary and alternative medicine and over-the-counter medication use in children's asthma management.Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current EvidenceComplementary and alternative medicine: a survey of its use in pediatric oncology.Clinical use of probiotics in the pediatric population.Attitudes, patterns of recommendation, and communication of pediatric providers about complementary and alternative medicine in a large metropolitan children's hospital.Use of complementary and alternative medicine by patients with inflammatory bowel disease.Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis.A review of the use of complementary and alternative medicines by children with inflammatory bowel disease.Parental attitudes toward pediatric use of complementary/alternative medicine in Turkey.The use of complementary/alternative therapies among children attending an urban pediatric emergency department.Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease.Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.COMPLEMENTARY AND ALTERNATIVE MEDICINE: A WORLD TO BE EXPLORED.Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic?Is it always necessary to treat CD patients?Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease.
P2860
Q21134510-93AFA2C1-8334-4986-9E61-89297CE4EB4FQ22252305-EE99AE34-3F7A-4FCA-B3CC-DAAF2EE88D7CQ24805409-F92CF30B-F3DF-4095-8E53-CD13D8B800F5Q27002496-6B34ABD5-DECC-436A-8909-71CAAA8828E6Q28067259-DE77B7BA-06CA-440F-8D55-34AA640CC4DAQ33244259-A14ECAE6-29B7-4108-9B0C-53CC40C0AC0EQ33286654-275C1482-A1C0-41CE-B0BD-8B743FFA9D61Q33326345-6D11B669-8D53-47BB-B98A-68D8B2A028BCQ33586875-F27DAD94-A38F-4007-9857-3FF928DCC170Q33653195-2E944721-2221-40E3-8F9E-A23153C0631CQ33913947-3B69CC46-3AF3-4531-AEF6-9CFBECF1E2D7Q33922082-E0EEA372-980C-4DE1-A27F-5E903C20614BQ33995802-1B259427-0456-427D-B68F-EE8F67FD32DDQ34049317-F32C9030-07FF-4CA4-97A3-BAED9647954DQ34514148-4BAED11D-86E5-415E-952C-E1287ECBA5C4Q34560319-2FA785CE-11D8-4D0F-AAF0-3F501983D096Q35079445-9719C5CE-94FE-4F90-A6BA-C78AD55408BCQ35124656-EBE227DF-E46C-4579-99C3-AC8696235F05Q35649251-69EC3053-F205-493F-B751-A0D47E974C90Q35768888-5031D76C-013F-4677-A6E6-2DD5F959C710Q36120936-08BA6300-57C7-465B-8C8A-A254C7A36436Q36840221-33CA5F51-F45C-4831-9F6D-7B5C90E0B60BQ37055823-EBC2EA27-2A23-42AC-A9DB-6E275B25258AQ37331785-0C617EF4-1527-4384-ACA2-44C4607020B4Q37401597-1D42C6BE-B825-4C7C-BCC6-56B8B4D3CAFCQ37734684-C632F5AE-BBC6-4B31-870E-292F621B41A3Q37789695-513AE775-28E7-4EF6-BBF7-DC7463F829C7Q38016381-E281CAB1-4A63-4979-82E6-0FE29E6704E5Q38176623-6980E437-7419-4687-BE48-1280777F8437Q38714434-D4C71654-5CF7-4BFD-9C14-98A3AD732D27Q39778338-E4536312-20FF-4450-988C-24B190CF698AQ40442352-C47AA456-0645-4102-B822-86D1A142B34EQ42641578-3193D623-00EC-4208-9556-75E7DE406593Q47926041-680B8036-9D25-4DE1-9817-85CD55BD88DFQ50216000-89F21C5F-B319-45A4-89D9-021953DD2620Q50740990-62AFE4ED-E429-4170-BAA5-B61942FC042BQ53129706-3DBE345D-E39C-406F-8EF3-0373F7FE1620Q53324592-FA892C2C-F9E4-4E2F-89D5-491AE4183E64
P2860
Complementary medicine use in children and young adults with inflammatory bowel disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Complementary medicine use in children and young adults with inflammatory bowel disease.
@en
Complementary medicine use in children and young adults with inflammatory bowel disease.
@nl
type
label
Complementary medicine use in children and young adults with inflammatory bowel disease.
@en
Complementary medicine use in children and young adults with inflammatory bowel disease.
@nl
prefLabel
Complementary medicine use in children and young adults with inflammatory bowel disease.
@en
Complementary medicine use in children and young adults with inflammatory bowel disease.
@nl
P2093
P2860
P1476
Complementary medicine use in children and young adults with inflammatory bowel disease.
@en
P2093
Alan Leichtner
Anne Wuerth
Athos Bousvaros
David Zurakowski
Kathi Kemper
Nadeem Afzal
Robert Heuschkel
Vasundhara Tolia
P2860
P304
P356
10.1111/J.1572-0241.2002.05474.X
P407
P577
2002-02-01T00:00:00Z